A novel histone deacetylase inhibitor exerts promising anti-breast cancer activity via triggering AIFM1-dependent programmed necrosis.

Cancer Commun (Lond)

Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021, P. R. China.

Published: November 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648389PMC
http://dx.doi.org/10.1002/cac2.12362DOI Listing

Publication Analysis

Top Keywords

novel histone
4
histone deacetylase
4
deacetylase inhibitor
4
inhibitor exerts
4
exerts promising
4
promising anti-breast
4
anti-breast cancer
4
cancer activity
4
activity triggering
4
triggering aifm1-dependent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!